Katlyn Nemani, M.D.
Dr. Katlyn Nemani is a clinical research psychiatrist at the Nathan Kline Institute and Research Assistant Professor of Psychiatry at the New York University School of Medicine. After earning her medical degree at Tufts University, she completed combined residency training in neurology and psychiatry at the NYU. Her goal is to advance and improve care for people with disorders at the interface of psychiatry and neurology with a cross-disciplinary approach. Prior to joining the Nathan Kline Institute she conducted clinical research at the Montreal Neurological Institute, Schizophrenia Research Program at Massachusetts General Hospital, and at NYU with mentorship from Dr. Donald Goff. Her research is focused on understanding the bidirectional relationship between systemic disease and psychopathology, particularly the interaction between the nervous system and immune system in people with psychosis. Her aim is to identify reversible mechanisms that may lead to novel therapeutics.
Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J, Petkova E, Goff DC. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA Psychiatry. 2021 Jan 27.
Nemani K, Gurin L. Neuropsychiatric Complications after Stroke. Semin Neurol. 2021 Jan 28.
Nemani KL, Greene MC, Ulloa M, et al. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. Clin Schizophr Relat Psychoses. 2019;12(4):168-176.
Nemani K, Hosseini Ghomi R, McCormick B, Fan X. Schizophrenia and the gut-brain axis. Prog Neuropsychopharmacol Biol Psychiatry. 2015; 56:155-160.
Song X, Pang L, Feng Y, Fan X, Li X, Zhang W, Gao J, Zhang J, Nemani K, Zhang H, Lv L. “Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.” Behav Brain Funct. 2014; 10(1): 35.